Application of RXR in screening of agonists of Ifnbeta, Isg15, Gbp-1, Oas2, Irf7, Isg20 and Ifn4
A gbp-1, agonist technology, applied in the field of biomedicine
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0054] RXR expression regulates host susceptibility to vesicular stomatitis virus infection:
[0055] Our previous genetic studies have established a novel interferon regulator 3-dependent but interferon-independent mechanism to downregulate RXR expression (Chow et al. 2006). To determine RXR expression levels by different types of viral infection, bone marrow-derived macrophages were infected with vesicular stomatitis virus. The results showed that the expression of RXR was down-regulated after infection with the above viruses (such as figure 1 shown in A). Repression of the RXR gene was not due to changes in the cell state after infection, as the L32 control gene was unchanged (data not shown). Administration of the RNA virus analogue polyI:C and the DNA virus analogue polydA:dT can activate intracellular virus and also significantly inhibit the expression of RXR in bone marrow macrophages. (Such as figure 1 Shown in B) More importantly, it confirms that this suppressi...
Embodiment 2
[0059] RXR agonists and their antagonists modulate host defense functions in vesicular stomatitis virus-injected macrophages:
[0060] Ligand binding to RXR can activate its downstream pathway, and it is fully activated. In order to explore whether RXR ligand activation can affect virus infection, RAW264.7 cells were pretreated overnight with RXR-specific agonists Ig268 and AGN194204, and then infected with vesicular stomatitis virus. Through plaque test analysis, the experimental results were consistent with the experimental results of RXR overexpression, and the RXR in the ligand activation group was given two stimulants, which significantly enhanced the level of vesicular stomatitis virus infection. (Such as Figure 7 Shown in A) Similarly, treatment with 9-cis retinoic acid (a new ligand for RXR) can also increase the susceptibility of RAW264.7 cell line to vesicular stomatitis virus infection in a dose-dependent manner ( Retinoic acid dosage range 16nM-20nM) (such as ...
Embodiment 3
[0062] Ligand activation of RXR inhibits the expression of multiple antiviral genes:
[0063] In order to study how RXR weakens the host immune response and facilitates virus infection, the inventors of the present invention performed gene chip detection on the RXR agonist pretreatment group and macrophage PolyI:C transfection group. The results show that 9 cis retinoic acid can inhibit a variety of Poly1:C-induced genes, including type 1 interferon genes (such as IFN1, IFN2, IFN4, IFN5) Isg15, Ifit3 and Gbp3 (such as image 3 A) Considering that type 1 interferon and its downstream interferon-stimulated gene ISGs play an important role in the host's immune response in antiviral infection, RXR-mediated inhibition of these antiviral genes may be the host's response to viral infection caused by susceptibility. In order to verify the genetic data and prove the hypothesis that RXR is beneficial to virus infection by inhibiting antiviral genes, the inventors pretreated RAW264.7 ce...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com